OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients</p>
Anna Pawłowska, Dorota Suszczyk, Rafał Tarkowski, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 9691-9709
Open Access | Times Cited: 13
Anna Pawłowska, Dorota Suszczyk, Rafał Tarkowski, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 9691-9709
Open Access | Times Cited: 13
Showing 13 citing articles:
Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies
Stephanie Pitts, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Stephanie Pitts, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Peripheral blood PD-1+ T lymphocytes as biomarkers in liquid biopsies for solid tumors: Clinical significance and prognostic applications
Mingjian Piao, Nan Zhang, Jiongyuan Li, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114052-114052
Open Access | Times Cited: 1
Mingjian Piao, Nan Zhang, Jiongyuan Li, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114052-114052
Open Access | Times Cited: 1
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1929-1929
Open Access | Times Cited: 29
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1929-1929
Open Access | Times Cited: 29
Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy
Elina Khatoon, Parama Dey, Aviral Kumar, et al.
Life Sciences (2022) Vol. 306, pp. 120827-120827
Closed Access | Times Cited: 20
Elina Khatoon, Parama Dey, Aviral Kumar, et al.
Life Sciences (2022) Vol. 306, pp. 120827-120827
Closed Access | Times Cited: 20
Characterization of alternative sPD-1 isoforms reveals that ECD sPD-1 signature predicts an efficient antitumor response
Ping Hou, Li Hu, Junrong Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Ping Hou, Li Hu, Junrong Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients
Anna Pawłowska, Agnieszka Kwiatkowska, Dorota Suszczyk, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11563-11563
Open Access | Times Cited: 25
Anna Pawłowska, Agnieszka Kwiatkowska, Dorota Suszczyk, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11563-11563
Open Access | Times Cited: 25
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
Anna Pawłowska, Wiktoria Skiba, Dorota Suszczyk, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5757-5757
Open Access | Times Cited: 16
Anna Pawłowska, Wiktoria Skiba, Dorota Suszczyk, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5757-5757
Open Access | Times Cited: 16
Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
Janina Świderska, Mateusz Kozłowski, Katarzyna Nowak, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 189-189
Open Access | Times Cited: 14
Janina Świderska, Mateusz Kozłowski, Katarzyna Nowak, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 189-189
Open Access | Times Cited: 14
The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
Simona Miceska, Erik Škof, Simon Buček, et al.
Radiology and Oncology (2023) Vol. 57, Iss. 4, pp. 493-506
Open Access | Times Cited: 6
Simona Miceska, Erik Škof, Simon Buček, et al.
Radiology and Oncology (2023) Vol. 57, Iss. 4, pp. 493-506
Open Access | Times Cited: 6
Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer
Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, et al.
Cancer Letters (2024) Vol. 611, pp. 217357-217357
Closed Access | Times Cited: 1
Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, et al.
Cancer Letters (2024) Vol. 611, pp. 217357-217357
Closed Access | Times Cited: 1
PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases
Caroline Eymerit-Morin, Anna Ilenko, Thomas Gaillard, et al.
European Journal of Histochemistry (2021) Vol. 65, Iss. 1
Open Access | Times Cited: 9
Caroline Eymerit-Morin, Anna Ilenko, Thomas Gaillard, et al.
European Journal of Histochemistry (2021) Vol. 65, Iss. 1
Open Access | Times Cited: 9
A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting
Sarah Libbrecht, Ann Vankerckhoven, Koen de Wijs, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 7-7
Open Access | Times Cited: 2
Sarah Libbrecht, Ann Vankerckhoven, Koen de Wijs, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 7-7
Open Access | Times Cited: 2
Clinical Significance of Tie-2-Expressing Monocytes/Macrophages and Angiopoietins in the Progression of Ovarian Cancer—State-of-the-Art
Wiktoria Skiba, Dorota Suszczyk, Anna Pawłowska, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3851-3851
Open Access | Times Cited: 3
Wiktoria Skiba, Dorota Suszczyk, Anna Pawłowska, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3851-3851
Open Access | Times Cited: 3
